CRDF

Cardiff Oncology, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-24

Figures on this page computed 2026-11-08 12:40 UTC

Last close

0.87USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-24

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-24
The filing itself
-170.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-08-11
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-08-11
The filing itself
-7732.0%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
The filing itself
-6402.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
The filing itself
0.02Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-08-11
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Margins is the furthest below its sector's middle: 0.02 against 0.23 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.35x

1.45x

1.44x

0.27x

0.05x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-24

Sales1.35x
Its own average over 10 years, 438.4K.
Profit1.45x
Its own average over 10 years, -31.6M.
Free cash flow1.44x
Its own average over 10 years, -26.4M.
Debt0.27x
Its own average over 10 years, 3.1M.
Price0.05x
Its own average over 11 years, 18. Market data, 2026-11-04

Price is furthest from its own average, at 0.05 times.

Sales is 1.35 times its own 10-year average; Profit is 1.45 times its own 10-year average; Free cash flow is 1.44 times its own 10-year average; Debt is 0.27 times its own 10-year average; Price is 0.05 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-24

Sales against its own 10-year average1.35
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
The filing itself
Profit against its own 10-year average1.45
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
The filing itself
Free cash flow against its own 10-year average1.44
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
The filing itself
Debt against its own 10-year average0.27
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-067464
Reported in
USD
The filing itself
Price against its own 11-year average0.05Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD